Business Context and Reporting Period
Company: Ekso Bionics Holdings, Inc. (Note: Input metadata referenced "Chronoscale Corp," but the filing text identifies Ekso Bionics Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 12, 2025
Reporting Period: Event-based report regarding a material definitive agreement entered into on September 12, 2025.
Key Financial Metrics and Transaction Details
This filing reports a new financing arrangement rather than periodic financial performance metrics (revenue, profit, cash flow). Key terms of the new agreement include:
- New Debt Facility: Secured term loan up to $2.0 million principal.
- Lender: B. Riley Commercial Capital, LLC.
- Interest Rate: 10.0% per annum, payable in full at maturity.
- Exit Fee: 10% of original principal ($200,000), payable at maturity.
- Maturity Date: September 14, 2026, or earlier upon a "Qualified Financing" (receipt of $2.4 million in net equity proceeds).
- Collateral: Substantially all personal property of the Company and its subsidiary.
- Conversion Option: Lender may convert principal, interest, and fees into equity during a Qualified Financing.
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes Versus Prior Period
Debt Restructuring: On September 12, 2025, the Company terminated a prior Loan and Security Agreement dated August 17, 2020, with Banc of California (formerly Pacific Western Bank). The Company paid off all obligations under the prior $2.0 million loan to facilitate the new agreement with B. Riley Commercial Capital, LLC.
Guidance, Risks, and Contingencies
Covenants: The agreement includes negative covenants limiting the Company's ability to incur additional debt, grant liens, dispose of assets, or make restricted payments, subject to specific exceptions.
Events of Default: Includes non-payment, covenant breaches, material adverse effects, bankruptcy, and change of control. Upon default, the lender may accelerate obligations and apply a default interest rate of 5.00% above the standard rate.
Related Party Transactions: An affiliate of the Lender may provide future banking or advisory services for customary fees.
Financial Outlook: The filing does not provide specific revenue guidance or management commentary on future operational performance beyond the financing terms.
Investor Verification Checklist
- Verify the exact amount drawn under the new $2.0 million facility versus the total available principal.
- Confirm the status of the "Qualified Financing" trigger ($2.4 million equity raise) and its impact on the loan maturity date.
- Review the full text of Exhibit 10.1 for specific definitions of "restricted payments" and asset disposal limitations.
- Assess the impact of the 10% exit fee and 10% interest rate on future cash flow requirements.
- Check for any subsequent filings regarding the conversion of debt to equity if a Qualified Financing occurs.